The role of galectin and CXC chemokine receptor in tumor progression of renal cell carcinoma
博士 === 國立陽明大學 === 醫學生物技術暨檢驗學系 === 102 === Renal cell carcinoma (RCC) is the most common kidney cancer noted in adult population. More than one-third of patients will present with locally advanced or metastatic disease at the time of diagnosis. Although targeted therapy has been the standard of care...
Main Authors: | Chang-Shuo Huang, 黃昶碩 |
---|---|
Other Authors: | Kuang-Hui Sun |
Format: | Others |
Language: | en_US |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/87459142018794245376 |
Similar Items
-
The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
by: Jan Korbecki, et al.
Published: (2021-01-01) -
The Role of CXC Chemokine Receptors 1–4 on Immune Cells in the Tumor Microenvironment
by: Katharina Helene Susek, et al.
Published: (2018-09-01) -
Expression of CXC Chemokine Receptor CXCR4 Enhances Basal Cell Carcinoma Tumorigenesis
by: Chao-Hong Liu, et al.
Published: (2004) -
CXC and CC Chemokines as Angiogenic Modulators in Nonhaematological Tumors
by: Matteo Santoni, et al.
Published: (2014-01-01) -
Study of the Structure and Function of CXC Chemokine Receptor 2
by: Kwon, Hae Ryong
Published: (2010)